Cargando…
Second and Third Generational Advances in Therapies of the Immune-Mediated Kidney Diseases in Children and Adolescents
Therapy of immune-mediated kidney diseases has evolved during recent decades from the non-specific use of corticosteroids and antiproliferative agents (like cyclophosphamide or azathioprine), towards the use of more specific drugs with measurable pharmacokinetics, like calcineurin inhibitors (cyclos...
Autores principales: | Grenda, Ryszard, Obrycki, Łukasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030090/ https://www.ncbi.nlm.nih.gov/pubmed/35455580 http://dx.doi.org/10.3390/children9040536 |
Ejemplares similares
-
Combined and sequential liver–kidney transplantation in children
por: Grenda, Ryszard, et al.
Publicado: (2018) -
Non-Hodgkin lymphoma after pediatric kidney transplantation
por: Grenda, Ryszard
Publicado: (2021) -
Comparison of Second- and Third-Generation Parathyroid Hormone Test Results in Patients with Chronic Kidney Disease
por: Wójtowicz, Magdalena, et al.
Publicado: (2020) -
Seminar on Second and Third Generation SPC PABXs
por: Collective
Publicado: (1983) -
Systematic Review of Safety and Efficacy of Second- and Third-Generation CD20-Targeting Biologics in Treating Immune-Mediated Disorders
por: Kaegi, Celine, et al.
Publicado: (2022)